Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
Completed
- Conditions
- Haemophilia B With InhibitorsHaemophilia A With InhibitorsHaemophilia BCongenital Bleeding DisorderHaemophilia A
- Interventions
- Other: No treatment given
- Registration Number
- NCT01988532
- Lead Sponsor
- Novo Nordisk A/S
- Brief Summary
This study is conducted in the United States of America (USA). The aim of the study is to assess the impact of pain on functional impairment and quality of life in adult persons with hemophilia (PWH) with and without inhibitors with joint bleeding.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 381
Inclusion Criteria
- Adult males able to provide consent and complete a survey in English
- Congenital hemophilia A or B with or without inhibitors with any history of joint bleeding or joint pain
- Presentation at the treatment center for a comprehensive annual visit where joint range of motion will be obtained
- Informed consent obtained before any study-related activities. (Study-related activities are any procedure related to recording of data according to the protocol)
Read More
Exclusion Criteria
- Previous participation in this study
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Adult PWH No treatment given -
- Primary Outcome Measures
Name Time Method Prevalence of acute (bleed-related) pain (percentage) At the first visit (only one study visit) Prevalence of chronic (arthritic) pain (percentage) At the first visit (only one study visit)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Novo Nordisk Investigational Site
🇺🇸Plainsboro, New Jersey, United States